** Neoleukin Therapeutics' shares fall 1.3% to 69 cents premarket

** Co says it will initiate a reverse stock split of its common stock at a ratio of 1-for-5

** Stock split will be effective from Sept. 25

** Says stock split is part of NLTX's plan to regain compliance with Nasdaq's minimum bid price requirement

** Up to last close, shares up 37.3% YTD

(Reporting by Christy Santhosh)

((Christy.Santhosh@thomsonreuters.com))